In this episode Brad Hightower, CEO at Hightower Clinical, and Darshan Kulkari, Regulatory and Compliance Attorney for the Life Sciences at The Kulkarni Law Firm join to discuss the 2022 Pharma Year in Review. Listen to discover: The biggest A-Ha moments and challenges for Pharma this year How they see the economic downturn having an impact on the industry Where data or technology innovation had the greatest impact on clinical trials and/or drug developments Whether FDA guidelines will be a motivator or a hindrance on things like trial diversity next year How they see social media channels and digital opinion leaders or influencers' impact on scientific communication and exchange evolving next year What they are most excited about for 2023 when it comes to innovation, trials or new developments in drug therapies To learn more about Hightower Clinical please use the links below:
- Website - LinkedIn To learn more about The Kulkarni Law Firm please use the links below:
- Website - LinkedInBe sure to also check out our guests' own podcasts:
Note to File, hosted by Brad HightowerDarshan Talks, hosted by Darshan Kulkarni
Sponsored by: H1 (https://www.h1.co/)To learn more about H1 please use the links below:- Website - LinkedInAlso, be sure to follow Slice of Healthcare on our social channels:- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter